Infection and persistence of erythrovirus B19 in benign and cancerous thyroid tissues

Journal of Medical Virology

Volumn 86, Issue 9, 2014, Pages 1614-1620

  Adamson, Laura A ^a   Fowler, Larry J ^a   Ewald, Amy S ^a   Clare Salzler, Michael J ^a   Hobbs, Jacqueline A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Erythrovirus; Integrin 5 1; P antigen; Thyroid

Indexed keywords

CAPSID PROTEIN; VERY LATE ACTIVATION ANTIGEN 5; VIRUS DNA; VIRUS PROTEIN; VIRUS RECEPTOR; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; EPITHELIUM CELL; ERYTHEMA INFECTIOSUM; GENE EXPRESSION; GENETIC ANALYSIS; GRAVES DISEASE; HUMAN; HUMAN PARVOVIRUS B19; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; STEM CELL; THYROID CANCER; THYROID DISEASE; THYROID METASTASIS; VERY ELDERLY; VIRUS DETECTION; VIRUS GENOME; VIRUS REPLICATION; ADENOMA; ERYTHROPARVOVIRUS; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; PAPILLARY CARCINOMA; PARVOVIRUS INFECTION; PATHOLOGY; SECONDARY; THYROID GLAND; THYROID TUMOR; VIROLOGY; YOUNG ADULT;

DNA VIRUSES; ERYTHROVIRUS; MIRIDAE;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAPSID PROTEINS; CARCINOMA, PAPILLARY; CHILD; DNA, VIRAL; ERYTHROVIRUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; RNA, VIRAL; THYROID GLAND; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84904036035     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23852     Document Type: Article

References (23)

1. Adamson LA, Fowler LJ, Clare-Salzler MJ, Hobbs JA. 2011. Parvovirus B19 infection in Hashimoto's thyroiditis, papillary thyroid carcinoma, and anaplastic thyroid carcinoma. Thyroid 21:411-417.
2. Brown KE, Anderson SM, Young NS. 1993. Erythrocyte P Antigen: Cellular receptor for B19 parvovirus. Science 262:114-117.
3. Dalton SL, Marcantoni EE, Assoian RK. 1992. Cell attachment controls fibronectin and alpha 5 beta 1 integrin levels in fibroblasts. Implications for anchorage-dependent and-independent growth. J Biol Chem 267:8186-8191.
4. Desailloud R, Hober D. 2009. Viruses and thyroiditis: An update. Virol J 6:5-18.
5. Hammond CJ, Hobbs JA. 2007. Parvovirus B19 infection of the brain: Possible role of gender in determining mental illness and autoimmune thyroid disorders. Med Hypotheses 69:113-116.
6. Heegaard ED, Brown KE. 2002. Human Parvovirus B19. Clin Microbiol Rev 15:485-505.
7. Hobbs JA. 2007. Parvovirus B19-brain interactions: Infection, autoimmunity, or both? J Clin Virol 38:364-365.
8. Kuethe F, Sigusch HH, Hilbig K, Tresselt C, Glck B, Egerer R, Figulla HR. 2007. Detection of viral genome in the myocardium: Lack of prognostic and functional relevance in patients with acute dilated cardiomyopathy. Am Heart J 153:850-858.
9. Kuethe F, Lindner J, Matschke K, Wenzel JJ, Norja P, Ploetze K, Schaal S, Kamvissi V, Bornstein SR, Schwanebeck U, Modrow S. 2009. Prevalence of Parvovirus B19 and Human Bocavirus DNA in the Heart of Patients with no Evidence of Dilated Cardiomyopathy or Myocarditis. Clin Infect Dis 49:1660-1666.
10. Kühl U, Pauschinger M, Seeberg B, Lassner D, Moutsias M, Poller W, Schultheiss HP. 2005. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112:1965-1970.
11. Lehmann HW, von Landenberg P, Modrow S. 2003. Parvovirus B19 infection and autoimmune disease. Autoimmun Rev 2:218-223.
12. Mori K, Munakata Y, Saito T, Tani J, Nakagawa Y, Hoshikawa S, Ozaki H, Yoshida K. 2007. Intrathyroidal persistence of human parvovirus B19 DNA in a patient with Hashimoto's thyroiditis. J Infect 55:e29-e31.
13. Munakata Y, Saito-Ito T, Kumura-Ishii K, Huang J, Kodera T, Ishii T, Hirabayashi Y, Koyanagi Y, Sasaki T. 2005. Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood 106:3449-3456.
14. Munshi NC, Zhou S, Woody MJ, Morgan DA, Srivastava A. 1993. Successful replication of parvovirus B19 in the human megakaryocytic leukemia cell line MB-02. J Virol 67:562-566.
15. Norja P, Hokynar K, Aaltonen LM, Chen R, Ranki A, Partio EK, Kiviluoto O, Davidkin I, Leivo T, Eis-Hübinger AM, Schneider B, Fischer H-P, Tolba R, Vapalahti O, Vaheri A, Söderlund-Venerno M, Hedman K. 2006. Bioportfolio: Lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA 103:7450-7453.
16. Page C, Hoffmann TW, Benzerdjeb N, Duverlie G, Sevestre H, Desailloud R. 2013. Detection of Erythrovirus B19 in Thyroidectomy Specimens from Graves' Disease Patients: A case-control study. J Med Virol 85:1414-1419.
17. Polcz ME, Adamson LA, Datar RS, Fowler LJ, Hobbs JA. 2011. Detection of parvovirus B19 capsid proteins in testicular tissues. Urology 79:744.e9-e15.
18. Tolfvenstam T, Papadogiannakis N, Anderson A, Akre O. 2002. No association between human parvovirus B19 and testicular germ cell cancer. J Gen Virol 83:2321-2324.
19. Tomer Y, Davies TF. 1993. Infection, thyroid disease, and autoimmunity. Endocr Rev 14:107-120.
20. Varner JA, Emerson DA, Juliano RL. 1995. Integrin alpha 5 beta 1 expression negatively regulates cell growth: Reversal by attachment to fibronectin. Mol Biol Cell 6:725-740.
21. Wang JH, Zhang WP, Liu HX, Wang D, Li YF, Wang WQ, Wang L, He FR, Wang Z, Yan QG, Chen LW, Huang GS. 2008. Detection of human parvovirus B19 in papillary thyroid carcinoma. Br J Cancer 98:611-618.
22. Wang J, Zhang W, Liu H, Wang D, Wang W, Li Y, Wang Z, Wang L, Zhang W, Huang G. 2010. Parvovirus B19 infection associated with Hashimoto's thyroiditis in adults. J Infect 60:360-370.
23. Weigel-Kelley KA, Yoder MC, Srivastava A. 2003. α5β1 integrin as a cellular coreceptor for human parvovirus B19: Requirement of functional activation of β1 integrin for viral entry. Blood 102:3927-3933.